Streetbeat News

Stock Prices

ARRY

Analysts have provided various ratings for Array Technologies (NASDAQ:ARRY) within the last quarter, with a total of 3 bullish, 3 somewhat bullish, and 2 somewhat bearish ratings. The company has an average 12-month price target of $29.0, an increase of 10.48% from the previous average price target of $26.25.

Portfolio Pulse from Benzinga Insights

September 28, 2023 | 1:00 pm

SHO

In the last quarter, Sunstone Hotel Invts (NYSE:SHO) received two indifferent and two somewhat bearish analyst ratings. The average 12-month price target for the stock, according to four analysts, is $9.25, representing a 3.85% decrease from the previous average price target of $9.62.

Portfolio Pulse from Benzinga Insights

September 28, 2023 | 1:00 pm

ASNS

GRTS

PTON

RNAZ

Several stocks are experiencing significant pre-market trading movements. Gritstone bio, Inc. (GRTS) shares rose 37% after the company was awarded a BARDA contract for a COVID-19 vaccine study valued at up to $433 million. TransCode Therapeutics, Inc. (RNAZ) shares gained 23% after pricing its $8 million public offering. Actelis Networks, Inc. (ASNS) shares surged 22.4% after achieving Third Party Validation for FIPS cyber protection standard. Peloton Interactive, Inc. (PTON) shares climbed 12.3% after announcing a five-year deal with Lululemon Athletica Inc (LULU).

Portfolio Pulse from Lisa Levin

September 28, 2023 | 12:54 pm

GRTS

Gritstone Bio Inc (NASDAQ:GRTS) has received a contract worth up to $433 million from the Biomedical Advanced Research and Development Authority (BARDA) to conduct a Phase 2b study of its self-amplifying mRNA (samRNA) vaccine candidate for COVID-19. The study, part of the U.S. Department of Health and Human Services' 'Project NextGen', will involve 10,000 participants and is expected to begin in Q1 2024. Following the news, GRTS shares rose 33.60% in premarket trading.

Portfolio Pulse from Vandana Singh

September 28, 2023 | 12:54 pm

LULU

PTON

Peloton Interactive Inc (PTON) and Lululemon Athletica Inc (LULU) have announced a five-year strategic global partnership. Under the deal, Peloton will become Lululemon's exclusive digital fitness content provider, while Lululemon will become the primary athletic apparel partner for Peloton. Co-branded apparel will be available from October 11, and Lululemon studio all-access members will gain access to Peloton classes for no additional cost from November 11. Lululemon plans to discontinue its Studio Mirror product and its digital app-only membership tier.

Portfolio Pulse from Adam Eckert

September 28, 2023 | 12:52 pm

NIO

NIO Inc (NYSE:NIO) shares are trading higher following reports of exploratory talks with Mercedes-Benz for a potential investment and technology alliance. However, the deal is reportedly facing pushback from Mercedes-Benz and is unlikely to be completed. Earlier, NIO shares traded lower after a report suggested the company was considering raising $3 billion from Middle East investors, which NIO denied.

Portfolio Pulse from Adam Eckert

September 28, 2023 | 12:50 pm

ASTI

Ascent Solar Technologies has announced the pricing of a public offering of units, leading to a decrease in its share price.

Portfolio Pulse from Benzinga Newsdesk

September 28, 2023 | 12:49 pm

BXRX

Baudax Bio has been granted orphan drug designation by the FDA for TI-168, a treatment for Hemophilia A with inhibitors. This news has led to a rise in the company's share prices.

Portfolio Pulse from Benzinga Newsdesk

September 28, 2023 | 12:48 pm

BNOX

Bionomics announced that its ATTUNE trial met its primary endpoint, showing that BNC210 treatment led to a significant reduction in total PTSD symptom severity at 12 weeks. This positive news has led to an increase in Bionomics' share price.

Portfolio Pulse from Benzinga Newsdesk

September 28, 2023 | 12:47 pm

CHS

Chico's FAS Inc (NYSE:CHS) shares are surging following the announcement of its acquisition by Sycamore Partners for $1 billion. Shareholders will receive $7.60 per share in cash, a 65% premium to its closing price on September 27, 2023. The deal includes a 30-day 'go-shop' period, allowing CHS to consider alternative acquisition proposals. The transaction is expected to close by Q1 2024, after which CHS will be de-listed from the NYSE.

Portfolio Pulse from Lekha Gupta

September 28, 2023 | 12:46 pm